纳米枸杞多糖合生元靶向微生态调节剂的制备及质量研究

目的制备合生元结肠靶向微生态调节剂,并建立其质量标准。方法球磨法制备枸杞多糖纳米粒,并将其与双歧杆菌、结肠粘附材料按一定比例装填入结肠靶向胶囊中,制备成合生元结肠靶向微生态调节剂;苯酚-硫酸法测定制剂中多糖含量,平板活菌计数法检测制剂中活菌数量。结果球磨法制备的枸杞多糖纳米粒成类球形,表面圆整,无粘连,80％粒径集中在464nm;合生元结肠靶向微生态调节剂符合2010版药典对胶囊剂的质量要求。结论按本法制备的合生元结肠靶向微生态调节剂安全可靠,其质量符合2010版药典对胶囊剂的质量要求。     

纳米山药多糖合生元结肠靶向微生态调节剂对 菌群失调动物免疫学指标的影响

摘要：目的 研究纳米山药多糖合生元结肠靶向微生态调节剂对抗生素脱污染菌群失调白兔的免疫学效应和机制。方法 用盐酸林可霉素建立菌群失调白兔模型,不同时间点取样,检测各组实验动物胸腺、脾脏指数,采用ELISA法,对各组实验动物肠黏膜sIgA、血清IL-2、IL-6进行检测。结果 各组指标检测结果,制剂组优于阳性对照组,差异有统计学意义（P<0.01）。结论 纳米山药多糖合生元结肠靶向微生态调节剂对抗生素脱污染菌群失调白兔免疫学指标有显著影响。     

纳米山药多糖合生元结肠靶向微生态调节剂对菌群失调动物生物学机制研究

目的 研究纳米山药多糖合生元结肠靶向微生态调节剂对抗生素脱污染菌群失调白兔的生物学效应和机制.方法 用盐酸林可霉素造成微生态失调白兔模型,不同时间点取盲肠内容物,采用标本菌落计数法,对治疗前后各组动物菌群数量进行检测,扫描电镜观察各组肠黏膜变化.结果 各组治疗后,双歧杆菌、乳酸菌、肠杆菌、肠球菌数量及肠黏膜恢复情况,制剂组优于阳性对照组及自然恢复组.结论 纳米山药多糖合生元结肠靶向微生态调节剂对抗生素脱污染菌群失调白兔有显著调节作用.     

甘草次酸结肠靶向微丸的研制

目的:确定甘草次酸结肠靶向微丸的制剂处方,评价其释药特性。方法:采用挤出-滚圆法制备甘草次酸素丸,利用流化床包衣技术对甘草次酸素丸进行包衣,用浆法评价微丸的体外释药性能。结果:采用微晶纤维素和甘草次酸,同时加入黏合剂羧甲基纤维素钠,经过充分搅拌混合,以30%的乙醇作为润湿剂,通过挤出-滚圆制得甘草次酸素丸。以尤特奇S100为膜控材料,加入适量柠檬酸三乙酯与滑石粉配制包衣液,对甘草次酸素丸进行包衣,制得甘草次酸包衣微丸。释放度实验表明甘草次酸素丸在其增重20%时,在0.1 mo L/L的盐酸溶液中不释放,在p H6.8的磷酸缓冲液条件下6 h内其释放率不到20%。而在p H7.4的磷酸缓冲液条件下2 h内释放率达到80%以上。结论:所制的甘草次酸素丸处方合理,制剂工艺简便,通过流化床包衣技术所制的甘草次酸包衣微丸在模拟的胃液中不释放,在小肠液中释放缓慢,在结肠液中释药良好,具有良好的结肠靶向作用。     

纳米山药多糖对大鼠免疫器官及巨噬细胞吞噬功能的影响

摘要：目的 研究纳米山药多糖合生元结肠靶向调节剂对大鼠免疫器官功能及巨噬细胞吞噬功能的影响。方法 以i.g盐酸林可霉素造成肠炎模型,将大鼠随机分成正常对照组,阳性对照组,纳米山药多糖组和模型组。测定胸腺和脾指数,中性红法测定巨噬细胞吞噬功能,MTT法测定T淋巴细胞增殖,ELISA法测定脾淋巴细胞IL-2和IFN-γ含量。结果 与模型组相比,纳米山药多糖组显著提高免疫器官指数,腹腔巨噬细胞吞噬能力,脾淋巴细胞增殖能力和IL-2和IFN-γ含量（P<0.05),且恢复到正常水平。结论 动物实验表明,纳米山药多糖结肠靶向微生态调节剂具有提高免疫器官指数、巨噬细胞吞噬功能、T淋巴细胞能力、IL-2和IFN-γ含量,是理想的中药微生态调节剂。     

纳米山药多糖合生元结肠靶向微生态调节剂对菌群失调大鼠免疫因子及SOD、MDA、NO、MPO表达的影响

目的探讨纳米山药多糖双歧杆菌合生元结肠靶向微生态调节剂对菌群失调模型大鼠的免疫因子及SOD(超氧化物歧化酶)、MDA(丙二醛)、NO(一氧化氮)、MPO(髓过氧化物酶)表达的影响。方法大鼠i.g盐酸林可霉素造成菌群失调伴有免疫缺陷肠炎模型,将大鼠随机分成靶向制剂组、阳性对照组和自然恢复组,紫外分光光度法检测结肠匀浆样本SOD、MDA、NO和MPO含量,微量溶血酶标仪分光光度法测定血清溶血素水平,ELISA法测定IL-1β(白细胞介素-1β)、IL-6(白细胞介素-6)、TNF-α(肿瘤坏死因子-α)、sIgA(分泌型免疫球蛋白A)及GM-CSF(粒细胞集落刺激生物因子)含量。结果与自然恢复组相比,纳米山药多糖组显著提高大鼠溶血素水平及sIgA、GM-CSF和SOD含量(P0.05),明显降低大鼠结肠样本中MDA、NO、MPO的含量(P0.05),IL-1β、IL-6和TNF-α在大鼠血清中的表达均有不同程度的下降(P0.05),且恢复到正常水平。结论纳米山药多糖双歧杆菌合生元结肠靶向微生态调节剂能减轻肠道炎症,提高溶血素水平、sIgA和GM-CSF含量,降低IL-1β、IL-6和TNF-α含量,提高机体免疫能力,是理想的中药微生态调节剂。     

纳米山药多糖合生元结肠靶向微生态调节剂对菌群失调

摘要：目的 探讨纳米山药多糖双歧杆菌合生元结肠靶向微生态调节剂对菌群失调模型大鼠的免疫因子及SOD（超氧化物歧化酶）、MDA（丙二醛）、NO（一氧化氮）、MPO（髓过氧化物酶）表达的影响。方法 大鼠i.g盐酸林可霉素造成菌群失调伴有免疫缺陷肠炎模型,将大鼠随机分成靶向制剂组、阳性对照组和自然恢复组,紫外分光光度法检测结肠匀浆样本SOD、MDA、NO和MPO含量,微量溶血酶标仪分光光度法测定血清溶血素水平,ELISA法测定IL-1β（白细胞介素-1β）、IL-6（白细胞介素-6）、TNF-α（肿瘤坏死因子-α）、sIgA（分泌型免疫球蛋白A）及GM-CSF（粒细胞集落刺激生物因子）含量。结果 与自然恢复组相比,纳米山药多糖组显著提高大鼠溶血素水平及sIgA、GM-CSF和SOD含量（P<0.05）,明显降低大鼠结肠样本中MDA、NO、MPO的含量（P<0.05）,IL-1β、IL-6和TNF-α在大鼠血清中的表达均有不同程度的下降（P<0.05）,且恢复到正常水平。结论 纳米山药多糖双歧杆菌合生元结肠靶向微生态调节剂能减轻肠道炎症,提高溶血素水平、sIgA和GM-CSF含量,降低IL-1β、IL-6和TNF-α含量,提高机体免疫能力,是理想的中药微生态调节剂。     

纳米山药多糖合生元结肠靶向微生态调节剂对菌群失调大鼠 免疫因子及SOD、MDA、NO、MPO表达的影响

摘要：目的 探讨纳米山药多糖双歧杆菌合生元结肠靶向微生态调节剂对菌群失调模型大鼠的免疫因子及SOD（超氧化物歧化酶）、MDA（丙二醛）、NO（一氧化氮）、MPO（髓过氧化物酶）表达的影响。方法 大鼠i.g盐酸林可霉素造成菌群失调伴有免疫缺陷肠炎模型,将大鼠随机分成靶向制剂组、阳性对照组和自然恢复组,紫外分光光度法检测结肠匀浆样本SOD、MDA、NO和MPO含量,微量溶血酶标仪分光光度法测定血清溶血素水平,ELISA法测定IL-1β（白细胞介素-1β）、IL-6（白细胞介素-6）、TNF-α（肿瘤坏死因子-α）、sIgA（分泌型免疫球蛋白A）及GM-CSF（粒细胞集落刺激生物因子）含量。结果 与自然恢复组相比,纳米山药多糖组显著提高大鼠溶血素水平及sIgA、GM-CSF和SOD含量（P<0.05）,明显降低大鼠结肠样本中MDA、NO、MPO的含量（P<0.05）,IL-1β、IL-6和TNF-α在大鼠血清中的表达均有不同程度的下降（P<0.05）,且恢复到正常水平。结论 纳米山药多糖双歧杆菌合生元结肠靶向微生态调节剂能减轻肠道炎症,提高溶血素水平、sIgA和GM-CSF含量,降低IL-1β、IL-6和TNF-α含量,提高机体免疫能力,是理想的中药微生态调节剂。     

地塞米松当归多糖前体药在大鼠胃肠道内容物中的释药特性

目的:探讨以当归多糖为载体的地塞米松前体药在大鼠胃肠道内容物中的释药特性,考察其结肠靶向性。方法:将前体药与大鼠胃肠道不同部位内容物稀释液于37℃共同孵育,不同时间点取样,高效液相色谱法检测释放的地塞米松(dexamethasone, DEX)及地塞米松琥珀酸单酯(dexamethasone hemisuccinate,DSH)。结果:前体药在大鼠胃肠道各部位内容物稀释孵育液中均有DEX及DSH释放;DEX在小肠近端的释放量最大,在结肠和盲肠中的释放量次之,在胃和小肠远端的释放量较小;DSH在结肠和盲肠中的释放量大,在胃、小肠近端和小肠远端释放量小;在160min孵育时间时,DEX和DSH在结肠和盲肠中的释放总量是在胃、小肠近端和小肠远端释放总量的1．95倍。结论:以当归多糖为载体的地塞米松前体药具有一定的结肠靶向释药特性,有可能用作局部治疗结肠炎的结肠靶向药物。     

柚皮素自微乳不对称膜渗透泵胶囊的制备及体外评价

制备柚皮素自微乳不对称膜渗透泵胶囊并考察其体外释药行为。实验利用球晶技术进行自微乳的固化研究,以醋酸纤维素浓度、栓模浸入聚合物溶液中时间、栓模浸入淬火液中时间为自变量,采用星点设计-效应面优化法,以囊壳厚度和24h药物累积释放度为因变量,确定不对称膜渗透泵胶囊壳的最佳制备工艺。其最佳制备工艺为:醋酸纤维素浓度9.44%,栓模浸入聚合物溶液中时间3.77min,栓模浸入淬火液中时间15.86min,按最佳工艺得到的药物累积释放度为96.27%,囊壳厚度为0.275mm。体外释药行为符合零级释药方程(R=0.9997)。柚皮素自微乳不对称膜渗透泵胶囊可有效控制药物缓慢释放,解决难溶性药物制成渗透泵制剂释药不完全的问题。     

The potential of organic-based amylose-ethylcellulose film coatings as oral colon-specific drug delivery systems

Amylose-ethylcellulose film coatings obtained from organic-based solvents were investigated as potential vehicles for colonic drug delivery. Amylose, in the form of an amylose-butan-1-ol dispersion, and ethylcellulose, dissolved in either ethyl lactate, ethanol, or propanol and plasticized with dibutyl sebacate, were mixed in various proportions and applied using a fluidized bed coater to achieve a range of film thicknesses on 5-aminosalicylic acid pellets. Drug release from the coated pellets was assessed under gastric and small intestinal conditions in the presence and absence of pepsin and pancreatin using dissolution methodology, and also within a simulated colonic environment involving fermentation testing with human feces in the form of a slurry. Under upper gastrointestinal tract conditions, the rate and extent of drug release were found to be related to the thickness of the coating and the ratio of amylose to ethylcellulose within the film. Modeling of the drug release data revealed that the ratio was more important than coat thickness in controlling drug release, irrespective of the solvent used for coating. Coatings with a thick film and/or low amylose content were relatively impermeable and able to delay drug release under conditions mimicking the upper gastrointestinal tract. Furthermore, drug release was unaffected by the presence of pepsin and pancreatin and by long-term storage. Under simulated colonic conditions, drug release was more pronounced from coating formulations containing higher proportions of amylose. Colon-specificity can therefore be achieved using such systems by judicious choice of the appropriate ratio of amylose to ethylcellulose and coat thickness.     

Dynamic and extensional properties of starch in aqueous dimethylsulfoxide

The effect of starch composition and concentration on the rheological properties of starch in a mixed solvent, water–DMSO, was investigated in dynamic shear and extensional mode. High amylose corn starch containing 70% amylose and 30% amylopectin, common corn starch containing 25% amylose and 75% amylopectin, and waxy corn starch containing about 99% amylopectin were used in this study. Concentrations of 2, 4, 6, and 8% (w/v) in 10% water-90% DMSO (v/v) were used for each starch type. An increase in the amylopectin content of starch from 30 to 99% caused a change in behavior from semidilute solution to viscoelastic solid at a concentration of 8% (w/v). At a concentration of 2%, an increase in the amylopectin content of starch from 30 to 99% caused a change from Newtonian to incipient gel-like behavior. Behavior at intermediate concentrations of 4 and 6% (w/v) varied from semidilute to critical gel-like with increasing amylopectin content. A power-law relaxation was observed for all concentrations of common and waxy corn starches with the slope decreasing with increase in concentrations. A 2% waxy corn starch solution displayed extension thinning behavior, while a 2% high amylose corn starch solution displayed Newtonian behavior.     

Influence of amylose content on starch films and foams

After extraction of smooth pea starch and waxy maize starch from pure amylose and amylopectin fractions, films with various amylose contents were prepared by casting in the presence of water or water with glycerol. For unplasticized films, a continuous increase in tensile strength (40–70 MPa) and elongation (4–6%) was observed as amylose increased from 0 to 100%. Discrepancies with values obtained for native starches with variable amylose content and different botanical origins were attributable to variations in the molecular weights of components. Taking cell wall properties into account, the values obtained in the laboratory were used to improve the relation between the flexural behavior of extruded foams and the model of cellular solids with open cavities.

The properties of plasticized films were not improved by the presence of glycerol and remained constant when amylose content was higher than 40%. Results are interpreted on the basis of topological differences between amylose and amylopectin.     

Role of starch as a substrate for Bacteroides vulgatus growing in the human colon

Bacteroides vulgatus is the numerically predominant Bacteroides species in the human colonic microflora. Unlike other colonic Bacteroides species, B. vulgatus is not a versatile utilizer of polysaccharides. The only types of polysaccharide that support rapid growth and high growth yields by all strains are the starches amylose and amylopectin. Amylase and alpha-glucosidase activities are among the highest found in a bacterial fraction obtained from human feces. This observation raised the question of whether B. vulgatus was the source of the fecal enzymes. Both alpha-glucosidase and amylase were produced at 20- to 40-fold-higher levels when B. vulgatus was grown on maltose, amylose, or amylopectin than when B. vulgatus was grown on glucose or other monosaccharides. Both enzymes had the same pI (4.6 to 5.0) and undenatured molecular weight (150,000). The pIs and molecular weights of the B. vulgatus amylase and alpha-glucosidase were the same as those of the fecal enzymes. To determine whether the B. vulgatus alpha-glucosidase was identical to the fecal alpha-glucosidase, we partially purified the B. vulgatus enzyme and raised an antiserum against it. Using this antiserum, we showed that all strains of B. vulgatus produced the same enzyme. The antiserum did not detect the B. vulgatus alpha-glucosidase in the bacterial fraction from human feces, even when a partially purified preparation of the fecal enzyme was used. Thus the alpha-glucosidase activity in the bacterial fraction from human feces is not the B. vulgatus enzyme.     

Role of starch as a substrate for Bacteroides vulgatus growing in the human colon.

Bacteroides vulgatus is the numerically predominant Bacteroides species in the human colonic microflora. Unlike other colonic Bacteroides species, B. vulgatus is not a versatile utilizer of polysaccharides. The only types of polysaccharide that support rapid growth and high growth yields by all strains are the starches amylose and amylopectin. Amylase and alpha-glucosidase activities are among the highest found in a bacterial fraction obtained from human feces. This observation raised the question of whether B. vulgatus was the source of the fecal enzymes. Both alpha-glucosidase and amylase were produced at 20- to 40-fold-higher levels when B. vulgatus was grown on maltose, amylose, or amylopectin than when B. vulgatus was grown on glucose or other monosaccharides. Both enzymes had the same pI (4.6 to 5.0) and undenatured molecular weight (150,000). The pIs and molecular weights of the B. vulgatus amylase and alpha-glucosidase were the same as those of the fecal enzymes. To determine whether the B. vulgatus alpha-glucosidase was identical to the fecal alpha-glucosidase, we partially purified the B. vulgatus enzyme and raised an antiserum against it. Using this antiserum, we showed that all strains of B. vulgatus produced the same enzyme. The antiserum did not detect the B. vulgatus alpha-glucosidase in the bacterial fraction from human feces, even when a partially purified preparation of the fecal enzyme was used. Thus the alpha-glucosidase activity in the bacterial fraction from human feces is not the B. vulgatus enzyme.     

Helical conformation of amylose in aqueous solution. I. Viscosity measurements

Two amylose samples, amylose V (DP_w = 2300) and amylose HE 15 (a low-substituted hydroxyethylamylose, DP_W = 1600) were studied. The intrinsic viscosity of the polymers in aqueous solution was measured with regard to its dependence on the alkalinity (0 to 5MNaOH), the ionic strength (0 to 5M), and the temperature (0 to 75°C). Additionally, the temperature dependence of the viscosity of the amylose-iodine complex was measured. It was found that the two amylose samples show the same dependence on the studied parameters. Therefore, it was concluded that the conformation is unchanged by the hydroxyethylation in the present case. In a discussion, steric, hydrodynamic, and thermodynamic data on amylose in solution are compared with the corresponding data on cellulose and dextran. The comparison leads to the conclusion that amylose in a neutral solution must have a helical conformation, corresponding to the well-accepted rod conformation of cellulose. The helical conformation also explains several viritual anomalies in the behavior of amylose. The results of the experiments support the helix model for amylose. The conclusion of the whole work, therefore, is that the amylose molecule in neutral aqueous solution can be regarded as a random coil, built up by helical segments. The average number of monomers per segment exceeds 100. This value decreases with increasing alkalinity.     

The priming of amylose synthesis in Arabidopsis leaves

We investigated the mechanism of amylose synthesis in Arabidopsis leaves using (14)C-labeling techniques. First, we tested the hypothesis that short malto-oligosaccharides (MOS) may act as primers for granule-bound starch synthase I. We found increased amylose synthesis in isolated starch granules supplied with ADP[(14)C]glucose (ADP[(14)C]Glc) and MOS compared with granules supplied with ADP[(14)C]Glc but no MOS. Furthermore, using a MOS-accumulating mutant (dpe1), we found that more amylose was synthesized than in the wild type, correlating with the amount of MOS in vivo. When wild-type and mutant plants were tested in conditions where both lines had similar MOS contents, no difference in amylose synthesis was observed. We also tested the hypothesis that branches of amylopectin might serve as the primers for granule-bound starch synthase I. In this model, elongated branches of amylopectin are subsequently cleaved to form amylose. We conducted pulse-chase experiments, supplying a pulse of ADP[(14)C]Glc to isolated starch granules or (14)CO(2) to intact plants, followed by a chase period in unlabeled substrate. We detected no transfer of label from the amylopectin fraction to the amylose fraction of starch either in isolated starch granules or in intact leaves, despite varying the time course of the experiments and using a mutant line (sex4) in which high-amylose starch is synthesized. We therefore find no evidence for amylopectin-primed amylose synthesis in Arabidopsis. We propose that MOS are the primers for amylose synthesis in Arabidopsis leaves.     

Effect of montmorillonite on morphology,glass transition and crystallinity of the xylitol-plasticized bionanocomposites

High amylose based nanocomposites plasticized by xylitol were prepared via twin-screw extrusion. The synergistic interaction in the xylitol-plasticized nanocomposite was studied via various characterization methods and the unique behavior of the xylitol-plasticized nanocomposite had been discussed. As revealed in the XRD and TEM results, good intercalated/exfoliated morphology had been achieved in all the nanocomposites. Furthermore, the expansion of nanoclay basal spacing was related to the xylitol/nanoclay ratio. DSC analysis clearly proved the unique crystallization process of xylitol-plasticized samples. Moreover, in the crystallization domain results, two domains sized at approximately 93.7 Å and 346 Å were found. This observation points to a two-level complex effect from two aggregate domains; one, the re-aggregation of certain number of silicate layers into domains which trap some of the amylose polymer chains, and two, the bulk drying process which combines smaller amylose crystalline domains within a larger amorphous high amylose matrix.     

Action of reactive oxygen species on colonic mucus secretions

Reactive oxygen species (ROS) have been implicated in the pathogenesis of many colonic diseases. Mucus is the colon's first line of defence against luminal agents. This study has therefore characterised ROS action on colonic mucus secretions. ROS were produced using peroxide-based systems of different concentrations. The effects of these systems were tested on native colonic mucus gels, isolated colonic mucins, and in vivo models. Colonic mucus gels were resistant to ROS breakdown. Mucins were susceptible to ROS attack, causing loss of terminal sugars and protein and mucin fragmentation. The in vivo thickness of the mucus barrier was reduced by up to 50% by ROS (above 5 mM peroxide). A 5 mM peroxide caused a significant increase in resting mucus thickness of ca. 15%. All ROS-generating systems caused mucosal damage once the loosely adherent mucus had been removed. As native mucus gel is more resistant to ROS damage than purified mucin, nonmucin components of mucus may have extensive ROS-scavenging properties. Low levels of luminal colonic ROS increase the protection afforded by the mucus barrier in vivo. Higher levels of ROS significantly reduce this protection. In vitro modeling of mucus degradation by ROS does not necessarily correlate with the dynamic, in vivo situation.